Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,029	1,323	537	1,632	771	192
Market Cap Growth	42.95%	146.40%	-67.12%	111.64%	302.10%	17.84%
Enterprise Value	1,707	982	303	1,311	471	76
PE Ratio	13.73	-16.75	-4.21	-13.00	-11.66	-2.48
PS Ratio	6.44	22.04	20.19	59.67	26.94	830.33
PB Ratio	3.62	3.93	2.49	5.44	2.76	2.40
P/FCF Ratio	-26.28	-18.67	-4.93	-14.98	-10.57	-4.51
P/OCF Ratio	-26.63	-18.83	-4.96	-15.13	-10.64	-4.62
EV/Sales Ratio	5.42	16.37	11.40	47.93	16.47	328.09
EV/EBITDA Ratio	10.11	-12.98	-2.44	-10.68	-7.66	-1.01
EV/EBIT Ratio	10.32	-12.44	-2.38	-10.44	-7.34	-0.98
EV/FCF Ratio	-21.26	-13.86	-2.78	-12.03	-6.46	-1.78
Debt / Equity Ratio	0.00	0.00	0.02	0.02	0.02	0.21
Debt / EBITDA Ratio	0.00	-0.02	-0.03	-0.05	-0.10	-0.23
Debt / FCF Ratio	-0.01	-0.02	-0.03	-0.05	-0.08	-0.40
Quick Ratio	15.60	16.53	7.61	7.46	7.66	3.95
Current Ratio	15.72	16.71	7.80	7.74	7.84	4.10
Asset Turnover	0.77	0.19	0.09	0.08	0.13	0.00
Interest Coverage	-	-	-	-	-107.44	-459.82
Return on Equity (ROE)	43.40%	-27.50%	-49.50%	-40.30%	-38.90%	-85.70%
Return on Assets (ROA)	39.60%	-25.30%	-42.90%	-35.30%	-29.30%	-52.30%
Return on Capital (ROIC)	25.97%	-27.72%	-59.92%	-41.14%	-22.59%	-83.03%
Earnings Yield	7.99%	-5.97%	-23.73%	-7.69%	-8.58%	-40.24%
FCF Yield	-3.16%	-5.36%	-20.29%	-6.68%	-9.46%	-22.15%
Buyback Yield / Dilution	-25.75%	-15.74%	-5.87%	-34.67%	-32.84%	-15.78%
Total Shareholder Return	-25.75%	-15.74%	-5.87%	-34.67%	-32.84%	-15.78%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).